|
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012.
more
By PBN Staff
|
|
A three-year, $105 million contract to build a new IT platform connecting the state of Rhode Island’s health care technology infrastructure has been awarded to Deloitte Consulting, Gov. Lincoln D. Chafee announced Thursday.
more
By Richard Asinof |
|
The Rhode Island Primary Care Physicians Corp., Rhode Island’s largest independent practice association, has formed an alliance with Rhode Island Behavioral Health Partners.
more
By PBN Staff
|
|
CVS Caremark Corp. and Rite Aid Corp., two of the largest U.S. drugstore chains, said they are running short of influenza vaccines as an earlier and more severe flu season drives up demand from Michigan to New Jersey.
more
By Shannon Pettypiece and Drew Armstrong |
|
Kent Hospital is expanding its cardiology care services with a new affiliation with Brigham and Women’s Hospital of Boston, hospital officials announced Tuesday.
more
By Richard Asinof |
|
The success of Rhode Island’s Health Benefits Exchange requires a “thoughtful approach,” according to a report from the Rhode Island Public Expenditure Council issued Wednesday.
more
By PBN Staff
|
|
The Providence Center has received a $128,615 grant from the Champlin Foundations to help fund new windows at the center’s 530 North Main St. location.
more
By PBN Staff
|
|
Brown University’s Program in Public Health will receive a major gift from the Irene Diamond Fund to establish an aging health initiative.
more
By PBN Staff
|
|
The Rhode Island Blood Center and Dunkin’ Donuts will kick off National Blood Donor Month and the “Give a Pint, Get a Pound” program on Jan. 7.
more
By PBN Staff
|
|
Mallinckrodt, the pharmaceuticals business of biotechnology giant Covidien PLC, has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of its Concerta tablets for the treatment of attention deficit hyperactivity disorder, the company announced Monday.
more
By PBN Staff
|